2-25742226-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018263.6(ASXL2):c.4111C>A(p.Gln1371Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00364 in 1,613,978 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 29 hom. )
Consequence
ASXL2
NM_018263.6 missense
NM_018263.6 missense
Scores
1
6
11
Clinical Significance
Conservation
PhyloP100: 9.27
Publications
11 publications found
Genes affected
ASXL2 (HGNC:23805): (ASXL transcriptional regulator 2) This gene encodes a member of a family of epigenetic regulators that bind various histone-modifying enzymes and are involved in the assembly of transcription factors at specific genomic loci. Naturally occurring mutations in this gene are associated with cancer in several tissue types (breast, bladder, pancreas, ovary, prostate, and blood). This gene plays an important role in neurodevelopment, cardiac function, adipogenesis, and osteoclastogenesis. [provided by RefSeq, Feb 2017]
ASXL2 Gene-Disease associations (from GenCC):
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Shashi-Pena syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00520885).
BP6
Variant 2-25742226-G-T is Benign according to our data. Variant chr2-25742226-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0038 (578/152278) while in subpopulation NFE AF = 0.00356 (242/68030). AF 95% confidence interval is 0.00319. There are 6 homozygotes in GnomAd4. There are 365 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 578 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ASXL2 | NM_018263.6 | c.4111C>A | p.Gln1371Lys | missense_variant | Exon 13 of 13 | ENST00000435504.9 | NP_060733.4 | |
| ASXL2 | NM_001369346.1 | c.3937C>A | p.Gln1313Lys | missense_variant | Exon 11 of 11 | NP_001356275.1 | ||
| ASXL2 | NM_001369347.1 | c.3331C>A | p.Gln1111Lys | missense_variant | Exon 10 of 10 | NP_001356276.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ASXL2 | ENST00000435504.9 | c.4111C>A | p.Gln1371Lys | missense_variant | Exon 13 of 13 | 5 | NM_018263.6 | ENSP00000391447.3 | ||
| ASXL2 | ENST00000336112.9 | c.4108C>A | p.Gln1370Lys | missense_variant | Exon 12 of 12 | 1 | ENSP00000337250.5 | |||
| ASXL2 | ENST00000404843.5 | c.2560C>A | p.Gln854Lys | missense_variant | Exon 10 of 10 | 1 | ENSP00000383920.1 |
Frequencies
GnomAD3 genomes AF: 0.00380 AC: 578AN: 152160Hom.: 6 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
578
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00495 AC: 1235AN: 249256 AF XY: 0.00482 show subpopulations
GnomAD2 exomes
AF:
AC:
1235
AN:
249256
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00362 AC: 5292AN: 1461700Hom.: 29 Cov.: 32 AF XY: 0.00355 AC XY: 2583AN XY: 727134 show subpopulations
GnomAD4 exome
AF:
AC:
5292
AN:
1461700
Hom.:
Cov.:
32
AF XY:
AC XY:
2583
AN XY:
727134
show subpopulations
African (AFR)
AF:
AC:
17
AN:
33480
American (AMR)
AF:
AC:
16
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
13
AN:
26136
East Asian (EAS)
AF:
AC:
1
AN:
39700
South Asian (SAS)
AF:
AC:
106
AN:
86254
European-Finnish (FIN)
AF:
AC:
1278
AN:
53400
Middle Eastern (MID)
AF:
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
3659
AN:
1111864
Other (OTH)
AF:
AC:
200
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
326
652
979
1305
1631
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00380 AC: 578AN: 152278Hom.: 6 Cov.: 32 AF XY: 0.00490 AC XY: 365AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
578
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
365
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
21
AN:
41562
American (AMR)
AF:
AC:
11
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
AC:
291
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
242
AN:
68030
Other (OTH)
AF:
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
8
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
31
ExAC
AF:
AC:
637
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 09, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ASXL2: BP4, BS1, BS2 -
Shashi-Pena syndrome Benign:1
Oct 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;T
Sift4G
Benign
T;T;T
Polyphen
P;.;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.